Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial

被引:0
作者
Wei, Lai [1 ]
Xie, Qing [2 ]
Hou, Jinlin [3 ]
Tang, Hong [4 ]
Ning, Qin [5 ]
Cheng, Jun [6 ]
Nan, Yuemin [7 ]
Zhang, Lunli [8 ]
Li, Jun [9 ]
Jiang, Jianning [10 ]
McNabb, Brian L. [11 ]
Zhang, Fangqiu [12 ]
Camus, Gregory [13 ]
Mo, Hongmei [13 ]
McNally, John [11 ]
Brainard, Diana M. [11 ]
Subramanian, Mani [11 ]
Gong, Guozhong [14 ]
Mou, Zhuangbo [15 ]
Wu, Shanming [16 ]
Wang, Qui-Qiang [17 ]
Hu, Peng [18 ]
Gao, Yanhang [19 ]
Jia, Jidong [20 ]
Duan, Zhongping [21 ]
机构
[1] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[4] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
[5] Huanzhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China
[6] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China
[7] Hebei Med Univ, Hosp 3, Shijiazhuang, Hebei, Peoples R China
[8] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
[9] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
[10] Guangxi Med Univ, Affiliated Hosp 1, Guangxi, Peoples R China
[11] Gilead Sci Inc, Clin Res, 353 Lakeside Dr, Foster City, CA 94404 USA
[12] Gilead Sci Inc, Biostat, 353 Lakeside Dr, Foster City, CA 94404 USA
[13] Gilead Sci Inc, Virol, 353 Lakeside Dr, Foster City, CA 94404 USA
[14] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China
[15] Jinan Infect Dis Hosp, Jinan, Shandong, Peoples R China
[16] Clin Ctr Shanghai Publ Hlth, Shanghai, Peoples R China
[17] Peking Univ, Hosp 1, Beijing, Peoples R China
[18] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China
[19] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China
[20] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China
[21] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1191
引用
收藏
页码:642A / 642A
页数:1
相关论文
共 50 条
[21]   Ledipasvir/sofosbuvir-based treatment of patients with chronic genotype-1 HCV infection and cirrhosis: results from two Phase II studies [J].
Lawitz, Eric ;
Poordad, Fred ;
Hyland, Robert H. ;
Wang, Jing ;
Liu, Lin ;
Dvory-Sobol, Hadas ;
Brainard, Diana M. ;
McHutchison, John G. ;
Gutierrez, Julio A. .
ANTIVIRAL THERAPY, 2016, 21 (08) :679-687
[22]   Safety and Efficacy of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Hepatitis C in Patients Aged 65 Years or Older: A Retrospective Analysis of Phase 3 [J].
Saab, Sammy ;
Mizokami, Masashi ;
Omata, Masao ;
Mangia, Alessandra ;
Eggleton, Ed ;
Seyedkazemi, Star ;
Zhu, Yanni ;
Knox, Steven J. ;
Pang, Phil ;
Subramanian, G. M. ;
Kowdley, Kris ;
Afdhal, Nezam H. .
GASTROENTEROLOGY, 2015, 148 (04) :S1085-S1085
[23]   Safety and Efficacy of Treatment with Once-Daily Ledipasvir/Sofosbuvir (90/400 mg) for 12 Weeks in Genotype 1 HCV-Infected Patients with Severe Renal Impairment [J].
Lawitz, Eric ;
Landis, Charles S. ;
Maliakkal, Benedict J. ;
Bonacini, Maurizio ;
Ortiz-Lasanta, Grisell ;
Zhang, Jie ;
Mogalian, Erik ;
De-Oertel, Shampa ;
Osinusi, Anu O. ;
Brainard, Diana M. ;
McHutchison, John G. ;
Flamm, Steven L. ;
Gordon, Stuart C. ;
Gane, Edward J. .
HEPATOLOGY, 2017, 66 :848A-848A
[24]   SAFETY AND EFFICACY OF TREATMENT WITH ONCE-DAILY LEDIPASVIR/SOFOSBUVIR (90/400 MG) FOR 12 WEEKS IN GENOTYPE 1 HCV-INFECTED PATIENTS WITH SEVERE RENAL IMPAIRMENT [J].
Lawitz, Eric ;
Landis, Charles S. ;
Maliakkal, Benedict J. ;
Bonacini, Maurizio ;
Ortiz-Lasanta, Grisell ;
Zhang, Jie ;
Mogalian, Erik ;
De-Oertel, Shampa ;
Osinusi, Anu O. ;
Brainard, Diana M. ;
McHutchison, John G. ;
Yip, Christina Sze Man ;
Huang, Hai Cheng ;
Flamm, Steven L. ;
Gordon, Stuart C. ;
Gane, Edward J. .
GUT, 2018, 67 :A99-A100
[25]   Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study [J].
Baatarkhuu, Oidov ;
Lee, Jae Seung ;
Amarsanaa, Jazag ;
Kim, Do Young ;
Ahn, Sang Hoon ;
Naranzul, Nyamsuren ;
Enkhtuya, Damba ;
Choijamts, Nagir ;
Batbayar, Purev ;
Otgonbayar, Radnaa ;
Saruul, Bat-Ulzii ;
Gantuul, Chuluunbaatar ;
Gegeebadrakh, Baljinnyam ;
Tuvshinbayar, Narangerel ;
Badamsuren, Dorjgotov ;
Ulzmaa, Galsan ;
Otgonbold, Jamiyandorj ;
Han, Kwang-Hyub .
CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (01) :125-135
[26]   SOFOSBUVIR/LEDIPASVIR WITH AND WITHOUT RIBAVIRIN FOR 8 WEEKS COMPARED TO SOFOSBUVIR/LEDIPASVIR FOR 12 WEEKS IN TREATMENT-NAIVE NON-CIRRHOTIC GENOTYPE-1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-3 STUDY [J].
Kowdley, K. V. ;
Stuart, G. C. ;
Reddy, R. K. ;
Rossaro, L. ;
Bernstein, D. E. ;
An, D. ;
Svarovskaia, E. S. ;
Hyland, R. H. ;
Pang, P. S. ;
Symonds, W. T. ;
Mchutchison, J. G. ;
Muir, A. J. ;
Pockros, P. J. ;
Pound, D. ;
Fried, M. W. .
JOURNAL OF HEPATOLOGY, 2014, 60 (01) :S23-S24
[27]   Safety and efficacy of sofosbuvir plus ledipasvir with and without ribavirin for chronic HCV genotype-1 infection: a systematic review and meta-analysis [J].
Ahmed, Hussien ;
Elgebaly, Ahmed ;
Abushouk, Abdelrahman Ibrahim ;
Hammad, Ali Mohamed ;
Attia, Attia ;
Negida, Ahmed .
ANTIVIRAL THERAPY, 2017, 22 (05) :369-379
[28]   Sofosbuvir/Ledipasvir With and Without Ribavirin for 8 Weeks Compared to Sofosbuvir/Ledipasvir for 12 Weeks in Treatment-Naive Non-Cirrhotic Genotype-1 HCV-Infected Patients: The Phase 3 Ion-3 Study [J].
Kowdley, Kris V. ;
Gordon, Stuart C. ;
Reddy, K. Rajender ;
Rossaro, Lorenzo ;
Bernstein, David ;
An, Di ;
Svarovskaia, Evguenia ;
Hyland, Rob H. ;
Pang, Phil ;
Symonds, William T. ;
McHutchison, John G. ;
Muir, Andrew J. ;
Pockros, Paul J. ;
Pound, David ;
Fried, Michael W. .
GASTROENTEROLOGY, 2014, 146 (05) :S926-S926
[29]   EFFICACY AND SAFETY OF SOFOSBUVIR/VELPATASVIR IN GENOTYPE 3 AND 6 HCV PATIENTS IN EAST CHINA [J].
Wang Donghui ;
Jiang, Suwen ;
Liu, Linsong ;
Fan, Lingyan ;
Hu, Airong .
HEPATOLOGY, 2021, 74 :589A-590A
[30]   Safety and Efficacy of Ledipasvir/Sofosbuvir without on-Treatment Laboratory Monitoring in HCV-Infected Rwandans: The Shared 2 Study [J].
Grant, Philip ;
Kabahizi, Jules ;
Mbituyumuremyi, Aimable ;
Van Nuil, Jennifer Ilo ;
Mukabatsinda, Constance ;
Damascene, Makuza Jean ;
Shumbusho, Fabienne ;
Ntirenganya, Cyprien ;
Nsanzimana, Sabin ;
Gupta, Neil .
HEPATOLOGY, 2018, 68 :36A-36A